Agnostic Detection of Synthetic Opioids and Other Illicit Drugs
ID: DHS241-001Type: Phase I
Overview

Topic

Agnostic Detection of Synthetic Opioids and Other Illicit Drugs

Agency

Department of Homeland SecurityScience and Technology Directorate

Program

Type: SBIRPhase: Phase IYear: 2024

Topic Link

https://www.sbir.gov/node/2476999

Additional Information

https://oip.dhs.gov/sbir/public
Timeline
  1. 1
    Release Nov 8, 2023 12:00 AM
  2. 2
    Open Dec 18, 2023 12:00 AM
  3. 3
    Next Submission Due Jan 18, 2024 12:00 AM
  4. 4
    Close Jan 18, 2024 12:00 AM
Description

The Department of Homeland Security (DHS) Small Business Innovation Research (SBIR) Program for FY24 is seeking proposals for the topic of "Agnostic Detection of Synthetic Opioids and Other Illicit Drugs". The research topic focuses on developing innovative methods to alert field personnel or personnel in a controlled environment to untargeted fentanyl-related substances in the presence of other compounds. The goal is to improve the detection capabilities of field detection devices, which currently rely on predetermined libraries of specific spectral signatures. The proposed solution should include requirements for both a handheld, battery-operated detector (Tier 1) and a portable detector that can be moved by a single person without wheeled assistance (Tier 2). The performance goals include the classification and identification of pure compounds and unknown narcotics, with minimal sample preparation and processing times of no more than 5 minutes for Tier 1 and 1 minute for Tier 2. The detection limits for unknowns should be at least 1% of the sample composition. Software solutions, such as AI/ML algorithms, are also encouraged. The project duration is not specified, and funding specifics can be found on the solicitation agency's website.

Files
No associated files provided.
Similar Opportunities
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of regulated therapeutic and diagnostic solutions for patients affected by Opioid and/or Stimulants use Disorders (OUD/StUD). The current drug crisis involving opioids and stimulants has resulted in a significant number of deaths and a need for comprehensive solutions. This funding opportunity aims to support research and development activities for novel medical products that address the needs of patients suffering from OUD/StUD. The two areas of focus for this solicitation are pharmacotherapeutics (small molecules and biologics) and medical therapeutic and diagnostic devices, including software as a medical device. The research topics may include the development of new medications, longer-acting formulations, advanced drug delivery systems, biomarkers, imaging technologies, therapeutic devices, in vitro diagnostic assays, and digital therapeutics. The projects proposed under this solicitation may fall under Phase I, Phase II, Fast Track, or Direct to Phase II categories. The funding opportunity is open until February 15, 2025. For more information and to apply, visit the grants.gov website or the National Institutes of Health's solicitation agency URL.
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of regulated therapeutic and diagnostic solutions for patients affected by opioid and/or stimulant use disorders (OUD/StUD). The current drug crisis surrounding these disorders has resulted in a significant number of deaths and an urgent need for comprehensive solutions. The solicitation is focused on the research and development of medical products regulated by the U.S. Food and Drug Administration (FDA), including pharmacotherapeutics and medical therapeutic and diagnostic devices. In the area of pharmacotherapeutics, the solicitation encourages the development of small or large molecule agents, biologics, natural products, longer-acting formulations of existing addiction medications, advanced drug delivery systems, and the development and characterization of biomarkers. Proposed activities may include target identification, assay development, lead optimization, preclinical studies, formulation development, and process development. The ultimate goal is to file an Investigational New Drug (IND) application and conduct clinical studies to support the filing of a New Drug Application (NDA) or a Biological License Application (BLA). In the area of medical therapeutic and diagnostic devices, the solicitation seeks research and development of imaging technologies, devices for diagnosing and reducing craving and withdrawal symptoms, therapeutic devices, devices for treating pediatric patients, in vitro diagnostic assays, digital therapeutics, devices for detecting and treating opioid-induced respiratory depression, and data science and cloud-based technologies. Proposed activities may include studies supporting an Investigational Device Exemption application, process development, non-clinical safety studies, clinical trials, and engagement with the FDA Center of Devices and Radiological Health. The goal is to successfully file an FDA premarket application for clearance/approval. The solicitation is open for applications and offers funding for Phase I, Phase II, and Fast Track projects. Phase I aims to establish the technical merit and feasibility of the proposed research, while Phase II continues the R&D efforts to advance the technology toward commercialization. Fast Track applications combine Phase I and Phase II into one application to reduce or eliminate the funding gap between phases. Small businesses that have received Phase I STTR awards are eligible to submit Phase II applications as "Renewal" applications.
Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of regulated therapeutic and diagnostic solutions for patients affected by opioid and/or stimulants use disorders (OUD/StUD). The current drug crisis surrounding OUD/StUD is a significant issue, with over 100,000 overdose deaths reported in a one-year period. The goal of this solicitation is to offer new medical products that can monitor, diagnose, and treat patients suffering from these disorders. The solicitation is open to small business companies that have developed or are developing FDA-regulated products for different indications and are interested in demonstrating their potential application in the OUD/StUD space. The research and development activities may fall into two areas: pharmacotherapeutics (small molecules and biologics) and medical therapeutic and diagnostic devices, including software as a medical device. The proposed projects should aim to address the needs of patients suffering from OUD/StUD and may include activities such as target identification, lead optimization, preclinical studies, formulation development, and clinical trials. The funding for these projects will be provided through the Small Business Innovation Research (SBIR) program, with Phase I and Phase II funding available. The application due dates are August 15, 2023, February 14, 2024, August 13, 2024, and February 14, 2025. For more information and to apply, interested parties can visit the grants.gov website or the solicitation agency URL provided.
DOD SBIR 24.4 Annual - Development of an Unmanned Aerial Systems (UAS) Passive Detection, Tracking, and Identification System for Ground Vehicles.
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of an Unmanned Aerial Systems (UAS) Passive Detection, Tracking, and Identification System for Ground Vehicles. The goal of this Army Small Business Innovative Research (SBIR) topic is to develop a passive sensor system capable of detecting, tracking, and identifying single and multiple drones threatening ground vehicles. The system should have a range of up to 2km and provide full hemispherical coverage. It should also include a soldier user interface control panel and the ability to alert at least one operator. The system should be able to operate in wooded/dense environments or large metropolitan areas and be installable on tactical and combat ground vehicles, including Army watercraft. In Phase I, the technical feasibility of passive sensors for drone detection will be determined through computer simulations. The possibility of using passive electromagnetic acoustic, optical, and other innovative sensing for processing multiple drone signatures will be demonstrated. The classification of drone signatures using these passive sensor systems will also be explored. In Phase II, the solution to achieve the capabilities outlined in Phase I will be developed. Optimum materials for the development of passive low-power consumption sensors for UAS detection, tracking, and identification will be identified. Principles of building networks of passive sensors that utilize fast processing capabilities will be developed, along with learning algorithms for drone identification. The system will be evaluated for compliance with the GVSC owned vehicle base kit in the GVSC Vehicle Protection Integration Lab (VPIL). A prototype system will be delivered to GVSC for evaluation and demonstration. Phase III will focus on expanding the capabilities of the solution to simulate different environments and conditions, demonstrating its applicability for municipal security, law enforcement, and commercial vehicles. The solicitation is open until March 31, 2025. For more information and to submit a proposal, visit the DOD SBIR website at [solicitation_agency_url].
DOD SBIR 24.4 Annual - Portable Diamond NV-Based Quantum Magnetometer for Enhanced Detection of Person-Borne Improvised Explosive Devices (PBIEDs)
Active
Department of Defense
The Department of Defense (DOD) is seeking proposals for the development of a portable Diamond Nitrogen-Vacancy (NV) Center-based Quantum Magnetometer for enhanced detection of Person-Borne Improvised Explosive Devices (PBIEDs). Quantum magnetometers utilizing Diamond NV technology offer significant advancements in sensitivity and precision for detecting minor fluctuations in magnetic fields. The magnetometers provide benefits such as exceptional sensitivity, robustness, durability, and non-invasive detection. However, challenges include manufacturing complexity, cost, false positives in metal-rich environments, and limitations in detection range and depth. The solicitation invites proposals for designing a portable Diamond NV-based Quantum Magnetometer that addresses these challenges and demonstrates a thorough understanding of operational contexts. The project will be conducted in three phases: Phase I involves foundational groundwork and design schematics, Phase II focuses on developing a working prototype, and Phase III involves refining the final deployable equipment and procedures. The development of a better magnetometer has the potential to provide significant benefits to numerous programs within the DoD. The deadline for proposal submission is March 31, 2025. For more information, visit the [solicitation link](https://www.sbir.gov/node/2651331).